October 4-5, 2021, Westin Copley Place, Boston, MA
Visit us at Booth # 9
Talk: Monday, October 04, 2021, 12:10 pm to 12:45 pm – Track: Predicting Clinical Outcome
Immunophenotyping of TCR and BCR clonotypes
TCR/BCR repertoire profiling holds great potential for understanding disease mechanisms. We introduce a novel technology for profiling of all human TCR and BCR variable regions and phenotypic characterization of immune cells in bulk and at the single-cell level in PBMCs and immune cell fractions. Preliminary data shows that TCR/BCR clonotype analysis combined with targeted expression profiling of immune cells can be applied for large-scale discovery in several immune-responsive model systems.
Presenter: Alex Chenchik, PhD, President and Chief Scientific Officer, Cellecta
